Validation of the 2020 Japanese classification criteria for juvenile dermatomyositis and polymyositis in a pediatric cohort in Japan

Clicks: 7
ID: 337443
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #49 of 49 articles by views in modern rheumatology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
BACKGROUND: The Japanese classification criteria for dermatomyositis (DM)/polymyositis (PM), revised in 2020, are applied to both pediatric and adult populations in Japan; however, their diagnostic performance in juvenile dermatomyositis (JDM) and juvenile polymyositis (JPM) remains unvalidated. METHODS: We conducted a retrospective validation study using the same multicenter dataset as in our previous validation of the EULAR/ACR classification criteria, comprising 68 physician-diagnosed JDM/JPM and 49 non-JDM/JPM controls from seven pediatric rheumatology centers in Japan between 2008 and 2015. Sensitivity and specificity of the Japanese classification criteria were calculated using the physician's final diagnosis as the reference standard and compared with existing classification criteria. RESULTS: The Japanese classification criteria classified 58 of 68 JDM/JPM patients and none of the controls, yielding a sensitivity of 85.3% and specificity of 100%. Sensitivity was slightly lower than that of the EULAR/ACR classification criteria (89.7%), but exceeded that of Bohan and Peter's criteria and Tanimoto's criteria. Ten patients were not classified as JDM/JPM, primarily due to absent muscle weakness despite supportive MRI or biopsy findings. CONCLUSIONS: The Japanese classification criteria demonstrate excellent specificity and good sensitivity for classifying patients with JDM/JPM. Their performance supports their use in pediatric practice, particularly with expanded myositis-specific autoantibody testing.
Reference Key
openalex_W7223788298 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Takayuki Kishi, Shinji Akioka, Norimoto Kobayashi, Akiko Ohta, Masaaki Mori, Ichiro Kobayashi
Are you one of these authors? Claim your profile
Journal modern rheumatology
Year 2026
DOI
10.1093/mr/roag090
URL
https://doi.org/10.1093/mr/roag090
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.